Current Assets Изменить Дата
Acadia Pharmaceuticals USD 499.17M 6.54M 2023-09
Alnylam Pharmaceuticals USD 2.99B 461.4M 2023-09
Amarin USD 717.51M 11.02M 2023-09
Amgen USD 48.48B 1.1B 2023-09
Arrowhead Research USD 419.52M 50.64M 2023-09
AstraZeneca USD 22.5B 338M 2023-09
Biogen USD 8.45B 1.98B 2023-09
Bluebird Bio USD 247.08M 40.9M 2023-09
Bristol-Myers Squibb USD 27.63B 442M 2023-09
Eli Lilly USD 23.01B 1.68B 2023-09
Enanta Pharmaceuticals USD 422.79M 25.67M 2023-09
Esperion Therapeutics USD 218.23M 13.9M 2023-09
Galectin Therapeutics USD 21.61M 2.14M 2023-09
Gilead Sciences USD 15.98B 1.69B 2023-09
GlaxoSmithKline GBP 21.24B 1.89B 2023-09
Incyte USD 4.4B 138.23M 2023-09
Ionis Pharmaceuticals USD 2.58B 32.1M 2023-09
Moderna USD 10.8B 200M 2023-09
Neurocrine Biosciences USD 1.65B 153.3M 2023-09
PTC Therapeutics USD 540.36M 49.33M 2023-09
Regeneron Pharmaceuticals USD 18.63B 1.71B 2023-09
Sarepta Therapeutics USD 2.45B 21.76M 2023-09
Vertex Pharmaceuticals USD 14.7B 822.9M 2023-09



Intercept Pharmaceuticals Текущие Активы - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2024.